Abixa Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

Full Prescribing Info

Adverse Reactions

In clinical trials in moderate to severe dementia, overall incidence rates for adverse events did not differ from placebo treatment and adverse events were usually mild to moderate in severity.
The following table gives an overview of the most frequent (>4% for memantine) adverse events (irrespective of causal relationship) that were observed in the trial population of patients with moderate to severe dementia. (See table.)

Click on icon to see table/diagram/image

Common adverse reactions (1-10% and more frequent than with placebo) for memantine and placebo patients respectively were: Hallucinations (2% vs 0.7%), confusion (1.3% vs 0.3%), dizziness (1.7% vs 1%), headache (1.7% vs 1.4%) and tiredness (1% vs 0.3%).
Uncommon adverse reactions (0.1-1% and more frequent than with placebo) were anxiety, hypertonia (increased muscle tone), vomiting, cystitis and increased libido.

View ADR Reporting Link

memantine

Manufacturer:

Lundbeck

Distributor:

Metro Drug